CCDC84 Activators
CCDC84 include a variety of compounds that induce intracellular signaling pathways leading to the protein's activation. Forskolin directly stimulates adenylate cyclase, which catalyzes the conversion of ATP to cAMP. This increase in cAMP levels activates protein kinase A (PKA), which can phosphorylate CCDC84, possibly altering its function. Similarly, IBMX raises cAMP levels by inhibiting phosphodiesterases that normally degrade cAMP. This inhibition ensures that cAMP accumulates in the cell, facilitating the activation of PKA and subsequent phosphorylation of CCDC84. PGE2 operates through its own receptors to activate adenylate cyclase, thereby enhancing cAMP production and PKA activation, which, in turn, can phosphorylate CCDC84. Epinephrine and Terbutaline, both adrenergic receptor agonists, also stimulate adenylate cyclase, leading to the same cascade of cAMP and PKA-mediated phosphorylation of CCDC84.
Histamine, through its H2 receptors, and Dopamine, via D1-like receptors, activate adenylate cyclase, thus promoting cAMP synthesis and PKA activation, culminating in CCDC84 phosphorylation. Anagrelide and Zardaverine, by inhibiting phosphodiesterase III and IV respectively, prevent cAMP degradation, which results in PKA activation and subsequent phosphorylation of CCDC84. Rolipram, as a selective inhibitor of PDE4, also increases cAMP levels, leading to the activation of PKA and the downstream phosphorylation of CCDC84. Adenosine interacts with A2 receptors to activate adenylate cyclase, boosting cAMP production and enabling PKA to phosphorylate CCDC84. Lastly, Cholera Toxin, by permanently activating Gs alpha subunit, triggers a prolonged increase in cAMP and robust PKA activation, which then leads to the phosphorylation of CCDC84. Each of these chemical activators works through distinct receptors or enzymes but converges on the pathway of cAMP and PKA to modulate the activity of CCDC84.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Isobutylmethylxanthine (IBMX) is a non-specific inhibitor of phosphodiesterases, leading to an increase in cAMP levels by preventing its degradation. This increase in cAMP may subsequently activate PKA, which could phosphorylate and activate CCDC84. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 (PGE2) interacts with its G-protein-coupled receptors, which can activate adenylate cyclase and increase intracellular cAMP levels, potentially leading to the activation of PKA and subsequent phosphorylation and activation of CCDC84. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine binds to adrenergic receptors, which can lead to the activation of adenylate cyclase and an increase in cAMP, thereby activating PKA. PKA can then potentially phosphorylate and activate CCDC84. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Histamine, through its H2 receptors, can activate adenylate cyclase, increasing cAMP and activating PKA. PKA may then phosphorylate and activate CCDC84 as part of its effector functions. | ||||||
Dopamine | 51-61-6 | sc-507336 | 1 g | $290.00 | ||
Dopamine can bind to its D1-like receptors, leading to the activation of adenylate cyclase and an increase in cAMP levels. This elevation of cAMP could activate PKA, which might phosphorylate and activate CCDC84. | ||||||
Anagrelide | 68475-42-3 | sc-491875 | 25 mg | $150.00 | ||
Anagrelide increases cAMP levels by inhibiting phosphodiesterase III. The resultant rise in cAMP could activate PKA, potentially leading to the phosphorylation and activation of CCDC84. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective inhibitor of phosphodiesterase 4 (PDE4), leading to increased cAMP levels in cells. This could lead to PKA activation, which may phosphorylate and activate CCDC84. | ||||||
Adenosine | 58-61-7 | sc-291838 sc-291838A sc-291838B sc-291838C sc-291838D sc-291838E sc-291838F | 1 g 5 g 100 g 250 g 1 kg 5 kg 10 kg | $34.00 $48.00 $300.00 $572.00 $1040.00 $2601.00 $4682.00 | 1 | |
Adenosine interacts with A2 receptors, which can activate adenylate cyclase and increase cAMP levels, leading to the activation of PKA. Activated PKA may phosphorylate and activate CCDC84. | ||||||
Terbutaline Hemisulfate | 23031-32-5 | sc-204911 sc-204911A | 1 g 5 g | $92.00 $378.00 | 2 | |
Terbutaline, a β2-adrenergic agonist, activates adenylate cyclase and increases cAMP levels, potentially leading to PKA activation. PKA can then potentially phosphorylate and activate CCDC84. | ||||||
Zardaverine | 101975-10-4 | sc-201208 sc-201208A | 5 mg 25 mg | $88.00 $379.00 | 1 | |
Zardaverine is a dual inhibitor of phosphodiesterase III and IV, resulting in increased cAMP levels and potentially activating PKA. This activation of PKA could lead to the phosphorylation and activation of CCDC84. | ||||||